Home LiteratureArticle Details
PMID: 16860762 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation.

Immunity ·Vol. 25 ·No. 1 ·2006-07-00 ·Pages 129-41

Mempel TR, Pittet MJ, Khazaie K, Weninger W, Weissleder R, von Boehmer H, von Andrian UH

Abstract

Mechanisms of dominant tolerance have evolved within the mammalian immune system to prevent inappropriate immune responses. CD4(+)CD25(+) regulatory T (T(reg)) cells have emerged as central constituents of this suppressive activity. By using multiphoton intravital microscopy in lymph nodes (LNs) of anesthetized mice, we have analyzed how cytotoxic T lymphocytes (CTLs) interact with antigen-presenting target cells in the presence or absence of activated T(reg) cells. Nonregulated CTLs killed their targets at a 6.6-fold faster rate than regulated CTLs. In spite of this compromised effector activity, regulated CTLs exhibited no defect in proliferation, induction of cytotoxic effector molecules and secretory granules, in situ motility, or ability to form antigen-dependent conjugates with target cells. Only granule exocytosis by CTLs was markedly impaired in the presence of T(reg) cells. This selective form of regulation did not require prolonged contact between CTLs and T(reg) cells but depended on CTL responsiveness to transforming growth factor-beta. CTLs quickly regained full killing capacity in LNs upon selective removal of T(reg) cells. Thus, T(reg) cells reversibly suppress CTL-mediated immunity by allowing acquisition of full effector potential but withholding the license to kill.

MeSH Terms
Animals Antigens/immunology Apoptosis/immunology B-Lymphocytes/cytology,immunology Cell Differentiation Cell Line Kinetics Mice Mice, Transgenic Signal Transduction T-Lymphocytes, Cytotoxic/immunology,metabolism T-Lymphocytes, Regulatory/immunology Transforming Growth Factor beta/metabolism
Chemicals
Antigens Transforming Growth Factor beta
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Mempel Thorsten R
CBR Institute for Biomedical Research and Department of Pathology, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115, USA.
Pittet Mikael J
Khazaie Khashayarsha
Weninger Wolfgang
Weissleder Ralph
von Boehmer Harald
von Andrian Ulrich H
Article Info
Journal
Immunity
Abbr.
Immunity
ISSN
1074-7613
Published
2006-07-00
Pages
129-41
Language
English
Region
United States
NLM ID
9432918
Subset
IM
Grants
NHLBI NIH HHS · P01-HL56949 · United States
NCI NIH HHS · P50-CA-86355 · United States
NIAID NIH HHS · R01-AI-061663 · United States
NCI NIH HHS · R01-CA104547 · United States
NCI NIH HHS · R01-CA96978 · United States
NHLBI NIH HHS · R01-HL54936 · United States
NCI NIH HHS · R24-CA92782 · United States
NIAID NIH HHS · R37 AI53102 · United States
NHLBI NIH HHS · T32-HL-066987-04 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com